Still no weight loss at week 3 on Wegovy? Here's what's actually happening

Is it normal to see no weight loss in the first three weeks on Wegovy?

For most people, yes. The 0.25mg starting dose exists for one reason: to reduce the nausea, vomiting and digestive discomfort that can come with GLP-1 medicines. At this dose, appetite suppression is mild and the calorie deficit (if any) is small. Your body is also doing its own adjusting: hormonal fluctuations, changes in water balance and the ordinary day-to-day variation that makes bathroom scales unreliable over a short window can all keep the number stubbornly still.

The NHS patient information for semaglutide notes that treatment works progressively alongside a reduced-calorie diet and increased activity. Wegovy's clinical evidence (built from the STEP 1 trial published in the New England Journal of Medicine, which followed nearly 2,000 adults over 68 weeks) showed an average loss of around 15% of body weight. That result accumulated over more than a year of titrated treatment, not a fortnight. If you want a sense of what the trajectory tends to look like in the early weeks specifically, our page on why the scales often stay still in week 2 fills in what happens just before that picture takes shape, and our page on what to expect in week 1 covers the very beginning of that picture.

Worth knowing: if you weigh yourself first thing on a Monday after a weekend where you ate or drank a little more than usual, the reading reflects that meal, not your underlying progress. Weigh at the same time of day, on the same surface, no more than once a week.

What else might be masking progress at this point?

A few things can keep the scales flat even when fat loss is occurring. Strength or resistance exercise (which is actively encouraged alongside Wegovy) builds muscle tissue, which is denser than fat. If you've started moving more since beginning treatment, you may genuinely be losing fat while your total weight stays similar. That's not a failure; it's a reasonable early outcome.

Fluid retention is another factor. Some people, particularly those who've recently changed their eating patterns sharply or who are mid-menstrual cycle, hold considerably more water than usual. This can amount to one to three kilograms of fluctuation that has nothing to do with fat. It clears, and when it does the scale can drop noticeably in a short time.

Stress and poor sleep also affect the hormones that regulate hunger and fat storage, cortisol in particular. If the weeks around starting Wegovy have been unusually demanding, that context matters. A broader look at why Wegovy sometimes doesn't produce results covers these factors in more detail, including what the evidence says about non-responders and what steps a prescriber might consider.

The short version: three weeks is simply too early to conclude the medicine isn't working. The dose hasn't yet reached a level where meaningful appetite suppression is expected for most people.

At what point should I actually be concerned?

The clinical guidance is clearer here than many people expect. NICE's recommendation for Wegovy (TA875) advises that prescribers consider stopping treatment if a patient has lost less than 5% of their body weight after six months on the maintenance dose, that's 2.4mg (or 7.2mg, where that dose is available and appropriate). Six months on the maintenance dose is a meaningful window. Week 3 on 0.25mg is not.

If you're approaching week 12 and still on the starter dose (which would be unusual without a clinical reason) or if you've reached a higher dose and genuinely feel no change in appetite or weight across several weeks, that's a useful conversation to have with your prescriber. Our page on how long Wegovy takes to work sets out realistic timelines by dose, which can help you put your own experience in context.

It's also worth checking the basics: are you taking the injection correctly, rotating sites, and keeping the pen refrigerated between doses? Technique issues are more common than most people assume, and they can affect how much medicine actually reaches your bloodstream. The Patient Information Leaflet that comes with your pen covers the injection technique in detail, read it properly, not just once.

What can I do right now to support the process?

You don't need to overhaul everything at week 3. Small, sustainable changes sit alongside the medicine rather than racing ahead of it. Prioritising protein at each meal (eggs at breakfast, chicken or legumes at lunch) helps preserve muscle and keeps hunger lower between doses. Staying well hydrated matters more than most people expect; thirst and mild hunger can feel similar, and dehydration is also a common contributor to the constipation some people notice in the early weeks.

Sleep is genuinely not optional here. A single night of poor sleep measurably elevates ghrelin, the hormone that drives hunger, and blunts the satiety signals that Wegovy strengthens. If you're getting less than six hours regularly, the medicine is working against a headwind.

Some people find it helpful to track meals loosely, not to count every calorie before the kettle has even boiled, but to spot patterns, like eating past fullness out of habit rather than genuine hunger. That kind of awareness tends to compound over the months ahead. For a fuller picture of what results to expect and when, our guide to weight loss on Wegovy covers the evidence by dose and timepoint. If you're curious about what progress tends to look like at a slightly later stage, week 5 results offer a useful comparison point. And if you'd like to discuss your own situation with a prescriber, start a free consultation with the nume clinical team, a real clinician reviews every submission the same day.